Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ANZUW NASDAQ:ATAKW NASDAQ:BEATW NASDAQ:DRTSW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANZUWAnzu Special Acquisition Corp I$0.06$0.05$0.00▼$0.15N/AN/A32,101 shs1 shsATAKWAurora Technology Acquisition$0.02-17.5%$0.01$0.01▼$0.04N/AN/A85,679 shs7,833 shsBEATWHeartBeam$0.31+20.7%$0.45$0.23▼$0.95N/AN/A10,967 shs1,756 shsDRTSWAlpha Tau Medical$0.25-9.1%$0.24$0.09▼$0.50N/AN/A20,747 shs1,057 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANZUWAnzu Special Acquisition Corp I0.00%0.00%+85.43%+62.25%+4.26%ATAKWAurora Technology Acquisition0.00%+3.23%+20.30%+66.67%+58.42%BEATWHeartBeam+21.24%+25.60%-18.02%-26.98%-61.23%DRTSWAlpha Tau Medical+0.37%+16.60%+16.10%+24.55%+9.60%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ABEATWHeartBeamN/AN/AN/AN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANZUWAnzu Special Acquisition Corp I 0.00N/AN/AN/AATAKWAurora Technology Acquisition 0.00N/AN/AN/ABEATWHeartBeam 0.00N/AN/AN/ADRTSWAlpha Tau Medical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/AN/AN/AN/AN/ABEATWHeartBeamN/AN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANZUWAnzu Special Acquisition Corp IN/AN/A0.00∞N/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ABEATWHeartBeamN/AN/A0.00∞N/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/AN/AN/AN/ABEATWHeartBeamN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANZUWAnzu Special Acquisition Corp IN/AATAKWAurora Technology AcquisitionN/ABEATWHeartBeamN/ADRTSWAlpha Tau MedicalN/AInsider OwnershipCompanyInsider OwnershipANZUWAnzu Special Acquisition Corp IN/AATAKWAurora Technology AcquisitionN/ABEATWHeartBeamN/ADRTSWAlpha Tau MedicalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANZUWAnzu Special Acquisition Corp I2N/AN/ANot OptionableATAKWAurora Technology AcquisitionN/AN/AN/ANot OptionableBEATWHeartBeam5N/AN/ANot OptionableDRTSWAlpha Tau Medical80N/AN/ANot OptionableBEATW, DRTSW, ANZUW, and ATAKW HeadlinesRecent News About These CompaniesDRTSW Alpha Tau Medical Ltd. WT EXPJuly 3, 2025 | seekingalpha.comAlpha Tau Medical Ltd. Approves Key Proposals at Annual MeetingJune 17, 2025 | tipranks.comAlpha Tau Medical Ltd. CFO Raphi Levy to Present at Jefferies Global Healthcare Conference on June 5, 2025May 28, 2025 | quiverquant.comQAlpha Tau Medical Ltd.: Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate UpdateMay 20, 2025 | finanznachrichten.deAlpha Tau receives FDA approval to start trial for patients with recurrent GBMApril 2, 2025 | markets.businessinsider.comCiti Sticks to Their Buy Rating for Alpha Tau Medical Ltd (DRTS)March 22, 2025 | markets.businessinsider.comAlpha Tau Medical Ltd.: Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate UpdateMarch 13, 2025 | finanznachrichten.deAlpha Tau Medical Ltd (DRTS) Gets a Buy from Piper SandlerMarch 13, 2025 | markets.businessinsider.comAlpha Tau receives MDSAP certificationFebruary 24, 2025 | markets.businessinsider.comAlpha Tau Achieves MDSAP Certification, Boosting Global Expansion EffortsFebruary 24, 2025 | tipranks.comDRTS Stock Soars to 52-Week High, Reaching $4.08 Amid Healthcare SurgeJanuary 17, 2025 | msn.comAlpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir ...December 18, 2024 | messenger-inquirer.comMAlpha Tau Medical Ltd. Appoints Maya Netser to Board of Directors as Meir Jakobsohn Completes TermDecember 17, 2024 | quiverquant.comQAlpha Tau to Showcase Innovations at Oncology SymposiumDecember 6, 2024 | tipranks.comAlpha Tau Medical Ltd. (DRTS)December 3, 2024 | finance.yahoo.comPositive Outlook for Alpha Tau Medical Ltd Amid Clinical and Regulatory MilestonesNovember 22, 2024 | markets.businessinsider.comPiper Sandler Issues a Buy Rating on Alpha Tau Medical Ltd (DRTS)November 21, 2024 | markets.businessinsider.comAlpha Tau Medical Advances in Cancer Treatment TechnologyNovember 20, 2024 | markets.businessinsider.comAlpha Tau Medical Ltd. Progresses with Alpha DaRT® as FDA Approves Key Trials and Financial Update Reveals Strong Cash PositionNovember 19, 2024 | quiverquant.comQAlpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 19, 2024 | markets.businessinsider.comMedia Sentiment Over TimeBEATW, DRTSW, ANZUW, and ATAKW Company DescriptionsAnzu Special Acquisition Corp I NASDAQ:ANZUW$0.06 0.00 (0.00%) As of 07/11/2025Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Aurora Technology Acquisition NASDAQ:ATAKW$0.02 0.00 (-17.53%) As of 07/11/2025Aurora Technology Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to focus on businesses in the technology companies, including artificial intelligence, blockchain, quantum computing, and electric vehicles in Asia and North America. The company was incorporated in 2021 and is based in San Francisco, California.HeartBeam NASDAQ:BEATW$0.31 +0.05 (+20.72%) As of 03:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company develops three-dimensional (3D)-vector electrocardiogram (ECG) platform for heart attack detection. It is developing HeartBeam AIMI software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack; and HeartBeam AIMIGo, a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.Alpha Tau Medical NASDAQ:DRTSW$0.22 -0.06 (-21.01%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
